Company Filing History:
Years Active: 2025
Title: Raghavender Chivukula: Innovator in TACI Binding Molecules
Introduction
Raghavender Chivukula is a notable inventor based in Hayward, California. He has made significant contributions to the field of biotechnology, particularly in the development of TACI binding molecules. His work has implications for therapeutic applications, showcasing his innovative spirit and dedication to advancing medical science.
Latest Patents
Raghavender Chivukula holds a patent for TACI binding molecules. This patent includes antibodies, fragments thereof, chimeric antigen receptors (CARs), and T cell receptors (TCRs) that comprise one or more of the dual TACI-BCMA binding domains. The patent also covers compositions, cells, and cell therapies that utilize these binding domains, along with methods of treatment.
Career Highlights
Chivukula is currently associated with Kite Pharma, Inc., a company known for its pioneering work in cell therapy. His role at Kite Pharma allows him to contribute to cutting-edge research and development in the field of immunotherapy.
Collaborations
Some of his notable coworkers include Jonathan Belk and Eugene Bolotin, who collaborate with him on various projects within the company.
Conclusion
Raghavender Chivukula's innovative work in TACI binding molecules exemplifies the impact of biotechnology on modern medicine. His contributions continue to pave the way for advancements in therapeutic treatments.